Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. (ALDX) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Lexington, United States and has 6 employees. The company is worth $38.93M. The share price is 89.1% below its 52-week high of $5.93. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $7.99M. In that quarter, 1 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -90.9% over 5Y.
today you would have $76.93▼ -92.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 12 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $5.18 | $4.99 | $3.51 | $6.96 | $4.00 | $6.86 | $5.81 | $8.30 | $6.80 | $5.35 | $6.78 | $7.22 | |
| P/B | 3.5x | 7.0x | 4.2x | 1.7x | 2.7x | 1.1x | 5.4x | 3.6x | 2.6x | 3.4x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BSEMBioStem Technologies, Inc. | $2.09 | 2.4x | 1.3x | 0.00% | -74.74% | $39.02M |
| VERUVERU Inc | $2.30 | — | 1.4x | 0.00% | -64.54% | $39.22M |
| RPIDRapid Micro Biosystems Inc | $0.76 | — | 2.2x | 0.00% | -141.65% | $38.34M |
| PRPOPrecipio, Inc. | $21.38 |
| 3.7x |
| 2.6x |
| 7.9x |
| EPS | -$0.56 | -$0.94 | -$0.64 | -$1.06 | -$1.07 | -$1.11 | -$2.24 | -$1.79 | -$1.40 | -$1.65 | -$1.40 | -$3.09 |
| ROE | -59.76% | -76.49% | -78.66% | -31.34% | -41.07% | -28.08% | -63.11% | -126.51% | -44.90% | -56.41% | -86.37% | -48.60% | -82.55% |
Median of the years shown; P/E years above 200x are left out.
| — |
| 2.6x |
| 0.00% |
| -8.98% |
| $38.27M |
| NEPHNephros Inc | $3.65 | 24.3x | 3.3x | 0.00% | 16.10% | $39.64M |
| GRCEGrace Therapeutics, Inc. | $1.89 | — | 0.6x | 0.00% | -36.19% | $39.76M |